We measured the alcohol sugars in sural nerves from 11 controls, 21 conventionally treated patients with diabetes and neuropathy, and 4 diabetics without neuropathy. The results were related to metabolic control and to clinical, neuropathological, and morphometric abnormalities in the nerves. The mean endoneurial glucose, fructose, and sorbitol values were higher in diabetic patients than in controls. Linear regression analysis revealed that nerve sorbitol content in the diabetics was inversely related to the number of myelinated fibers (P = 0.003). Mean nerve levels of myo-inositol were not decreased in the diabetic patients, with or without neuropathy, and were not associated with any of the neuropathological end points of diabetes. Our results indicate that myo-inositol deficiency is not part of the pathogenesis of human diabetic neuropathy, as had been hypothesized. Other accumulated alcohol sugars, however, were increased in diabetes and were associated with the severity of neuropathy. On repeat biopsy, six diabetics, treated for a year with the aldose reductase inhibitor sorbinil, had decreased endoneurial levels of sorbitol (P less than 0.01) and fructose (0.05 less than P less than 0.1), but unchanged levels of myo-inositol.
Source Information
Peripheral Nerve Laboratory, Mayo Clinic, Rochester, MN 55905.
This article has been cited by other articles:
Sivenius, K., Pihlajamaki, J., Partanen, J., Niskanen, L., Laakso, M., Uusitupa, M.
(2004). Aldose Reductase Gene Polymorphisms and Peripheral Nerve Function in Patients With Type 2 Diabetes. Diabetes Care
27: 2021-2026
[Abstract][Full Text]
Polydefkis, M., Hauer, P., Sheth, S., Sirdofsky, M., Griffin, J. W., McArthur, J. C.
(2004). The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain
127: 1606-1615
[Abstract][Full Text]
Boulton, A. J.M., Malik, R. A., Arezzo, J. C., Sosenko, J. M.
(2004). Diabetic Somatic Neuropathies. Diabetes Care
27: 1458-1486
[Full Text]
Bril, V., Ono, Y., Buchanan, R. A.
(2004). Sural Nerve Sorbitol in Patients With Diabetic Sensorimotor Polyneuropathy. Diabetes Care
27: 1160-1163
[Abstract][Full Text]
Malik, R.
(2003). Failure to define the pathogenesis and treatment of human diabetic neuropathy. British Journal of Diabetes & Vascular Disease
3: 107-111
[Abstract]
Yuen, K. C.J., Baker, N. R., Rayman, G.
(2002). Treatment of Chronic Painful Diabetic Neuropathy With Isosorbide Dinitrate Spray: A double-blind placebo-controlled cross-over study. Diabetes Care
25: 1699-1703
[Abstract][Full Text]
OBROSOVA, I. G., VAN HUYSEN, C., FATHALLAH, L., CAO, X., STEVENS, M. J., GREENE, D. A.
(2000). Evaluation of {alpha}1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J.
14: 1548-1558
[Abstract][Full Text]
Heesom, A. E, Millward, A., Demaine, A. G
(1998). Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5' end of the aldose reductase gene. J. Neurol. Neurosurg. Psychiatry
64: 213-216
[Abstract][Full Text]
AL-QATTAN, M. M., MANKTELOW, R. T., BOWEN, C. V. A.
(1994). Outcome of Carpal Tunnel Release in Diabetic Patients. J Hand Surg Eur Vol
19: 626-629
[Abstract]
Cohen, S. M., Mathews, T.
(1991). Pentoxifylline in the Treatment of Distal Diabetic Neuropathy. ANGIOLOGY
42: 741-746
[Abstract]
Szwergold, B., Kappler, F, Brown, T.
(1990). Identification of fructose 3-phosphate in the lens of diabetic rats. Science
247: 451-454
[Abstract]
(1988). DIABETIC NEUROPATHY MAY BE SECONDARY TO BUILDUP OF ALCOHOL SUGARS. JWatch General
1988: 5-5
[Full Text]
Previous
